Effect of High-Flow Humidified Oxygen on Ventilatory Work During the Spontaneous Breathing Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Grenoble

About this trial

Weaning from mechanical ventilation (MV) accounts for a significant portion of the total MV duration, and failure to extubate or delayed extubation increases complications (particularly Ventilator-Associated Pneumonia (VAP)) and mortality. Standard tests (T-piece, Spontaneous Ventilation with Inspiratory Assistance (SV-IA)) have not demonstrated clear superiority, and the T-piece is still widely used despite its limitations. High-flow oxygen (HFO) may reduce ventilatory work and facilitate secretion clearance; however, there is a lack of physiological data in humans with an endotracheal tube in place. This study aims to address this gap prior to a subsequent clinical evaluation.

An experimental, prospective, single-center, 3-period crossover study with randomized sequence order and single-blind design (primary endpoint assessment and statistical analysis were conducted in a blinded manner).

Eligibility criteria

Qualifiers

Adult patient, of legal age

On invasive mechanical ventilation for more than 48 hours

Age > 65 years

Chronic respiratory disease

Disqualifiers

Resuscitation-associated neuromyopathy

History of neuromuscular disease

Admission for a neurological condition

Subjects currently excluded from another study,

Trial design

Treatments tested in this trial

  • T piece
  • PSV
  • HFO

Treatment groups

30 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Locations

This trial has no locations

Sponsors and collaborators